Adaptive Clinical Trials as Topic
"Adaptive Clinical Trials as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Works about clinical studies in which a prospectively planned opportunity is included to modify trial designs and hypotheses based on analysis of data from subjects in the study .
| Descriptor ID |
D000075522
|
| MeSH Number(s) |
E05.318.760.250.500.100 N05.715.360.775.088.500.100 N06.850.520.450.250.250.100
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Adaptive Clinical Trials as Topic".
Below are MeSH descriptors whose meaning is more specific than "Adaptive Clinical Trials as Topic".
This graph shows the total number of publications written about "Adaptive Clinical Trials as Topic" by people in this website by year, and whether "Adaptive Clinical Trials as Topic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 2 | 2 |
| 2022 | 0 | 2 | 2 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adaptive Clinical Trials as Topic" by people in Profiles.
-
Candidate anti-tuberculosis medicines and regimens under clinical evaluation. Clin Microbiol Infect. 2024 Sep; 30(9):1131-1138.
-
Tumor-agnostic baskets to N-of-1 platform trials and real-world data: Transforming precision oncology clinical trial design. Cancer Treat Rev. 2024 Apr; 125:102703.
-
The New NCI Precision Medicine Trials. Clin Cancer Res. 2023 12 01; 29(23):4728-4732.
-
The NCI-MATCH trial: lessons for precision oncology. Nat Med. 2023 Jun; 29(6):1349-1357.
-
Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial. Ann Intern Med. 2022 12; 175(12):1716-1727.
-
Association of Residual Ductal Carcinoma In Situ With Breast Cancer Recurrence in the Neoadjuvant I-SPY2 Trial. JAMA Surg. 2022 11 01; 157(11):1034-1041.
-
Clinical trial design in the era of precision medicine. Genome Med. 2022 08 31; 14(1):101.
-
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19. Ann Intern Med. 2022 10; 175(10):1401-1410.
-
The Bayesian Time Machine: Accounting for temporal drift in multi-arm platform trials. Clin Trials. 2022 10; 19(5):490-501.
-
Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies. Cancer Cell. 2022 06 13; 40(6):609-623.e6.